Carroll Financial Associates’s Cardiff Oncology CRDF Stock Holding History

Carroll Financial Associates’s Portfolio CRDF Stock Details CRDF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-3,710	Closed	-$66K	–	1641
2020 Q4	$66K	Buy	+3,710	New	+$65.2K	﹤0.01%	619
2019 Q4	–	Sell	-21	Closed	–	–	1553
2019 Q3	$0	Hold	21	–	–	﹤0.01%	1542
2019 Q2	$0	Hold	21	–	–	﹤0.01%	1586
2019 Q1	$0	Hold	21	–	–	﹤0.01%	1383
2018 Q4	$0	Hold	21	–	–	﹤0.01%	1298
2018 Q3	$0	Buy	+21	New	+$99	﹤0.01%	1306
2018 Q2	–	Sell	-21	Closed	–	–	1263
2018 Q1	$0	Hold	21	–	–	﹤0.01%	1255
2017 Q4	$0	Hold	21	–	–	﹤0.01%	1238
2017 Q3	$1K	Hold	21	–	–	﹤0.01%	1136
2017 Q2	$1K	Buy	+21	New	+$1.35K	﹤0.01%	1134

Other funds holding CRDF

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Corriente Advisors Fort Worth, Texas $9.53M AUM 805.26% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

Carroll Financial Associates's CRDF Position: Q1 2021 in Review

Carroll Financial Associates sold out of Cardiff Oncology (CRDF) in Q1 2021, closing a stake of 3,710 shares — an estimated $66K sold.

Carroll Financial Associates first reported a position in CRDF in Q2 2017 and held it in 10 quarters. The position peaked at $66K in Q4 2020. 73 funds tracked by Wall St. Rank hold CRDF as of Q1 2021.

Carroll Financial Associates reported no remaining Cardiff Oncology position as of Q1 2021 after selling out during the quarter.
Carroll Financial Associates sold 3,710 Cardiff Oncology shares in Q1 2021, an estimated $66K.
Carroll Financial Associates first reported a position in Cardiff Oncology in Q2 2017 and held it in 10 quarters.
Carroll Financial Associates's Cardiff Oncology position peaked at $66K in Q4 2020.
73 funds tracked by Wall St. Rank held Cardiff Oncology as of Q1 2021.

Based on Carroll Financial Associates's 13F filing for Q1 2021, filed 6 Apr 2021.